Canada-based Canopy Growth (NASDAQ:CGC) has been eyeing the U.S. pot market for some time. In 2019, the pot producer rocked the cannabis industry when it said it agreed to a deal to acquire multistate operator
Acreage Holdings. But with marijuana illegal in the U.S., the deal remains on hold pending major legal changes.
However, Canopy Growth s CEO David Klein is optimistic that legalization will take place sooner rather than later. In a recent interview on Bloomberg, he said, we re pretty confident we ll be operating in the U.S. a year from now. It s a pretty bold statement considering that there has been little progress on marijuana legislation at the federal level, even in just the past year. Is Klein being too optimistic? Let s take a closer look at the state of the U.S. pot market today and whether it s likely that Canopy Growth will be operating there within the next 12 months.
Is Curaleaf Stock a Buy? David Jagielski
Multistate cannabis operator
Curaleaf (OTC: CURLF) is among the largest players in the industry. Its aggressive growth strategy focuses on expansion and big acquisitions. Today, the company s operations span 23 states and include 96 dispensaries. Curaleaf is a beast and offers investors a way to tap into the industry s explosive growth.
But it s not without risks, either. All that growth costs money and can be difficult to manage and integrate. The company continuously posts losses and burns through cash which can be a quick way to run into trouble in the industry. Is Curaleaf an exciting growth stock to invest in, or could the company s aggressive strategy be its undoing? Let s take a look and see which scenario is more likely, and whether you should consider buying shares of Curaleaf today.
The Globe s stars and dogs for the week - The Globe and Mail theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.